Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination

2017

Consider rituximab as a possible treatment for combined central and peripheral demyelination.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

7

References

2

Citations